West Pharmaceutical Services | WST - Ebitda

Stock Price
306.16
Daily Change
-3.54 -1.14%
Monthly
23.94%
Yearly
42.70%
Q2 Forecast
299.61

West Pharmaceutical Services reported $226.2M in EBITDA for its fiscal quarter ending in March of 2026.





Ebitda Change Date
Align Technology USD 183.84M 19.77M Sep/2025
Avanos Medical USD 10M 73.9M Sep/2025
Baxter International USD 426M 36M Sep/2025
Becton, Dickinson and Co. USD 1.71B 433M Dec/2025
Charles River Laboratories USD 258.06M 24.83M Dec/2025
Cooper Companies USD 323.4M 13.2M Dec/2025
Dentsply International USD 135M 32M Dec/2025
Haemonetics USD 115.53M 9.22M Sep/2025
ICU Medical USD 98.19M 27.67M Dec/2025
Insulet USD 194M 34M Dec/2025
Integra LifeSciences USD 104.21M 25.76M Dec/2025
IQVIA Holdings USD 1.05B 97M Dec/2025
J&J USD 7.19B 2.32B Dec/2025
Medtronic USD 2.93B 482M Dec/2025
Merit Medical Systems USD 97.23M 17.69M Dec/2025
Neogen USD 48.2M 546K Dec/2025
OraSure Technologies USD -17.7M 4.06M Dec/2025
Quidel USD 153.3M 23.8M Dec/2025
Repligen USD 39.54M 3.61M Dec/2025
Solventum Corp USD 437M 38M Dec/2025
STAAR Surgical USD -159K 34.78M Dec/2025
Terumo JPY 69.99B 3.22B Dec/2025
West Pharmaceutical Services USD 226.2M 7.7M Mar/2026